MedTrace Logo

Prevalence of BRCA1 and BRCA2 Mutations in Ovarian Cancer Patients in the Gulf Region

NCT03082976 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 108

Last updated 2020-07-16

No results posted yet for this study

Summary

A prospective, multi-centre, epidemiological observational study designed to evaluate the prevalence of BRCA1 and BRCA2 (BReast CAncer gene) mutations in current and newly diagnosed ovarian cancer patients across different countries in the Gulf region. This study will also describe the epidemiological features for the disease for the enrolled patients.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Mohammed Jaloudi, MD · Tawam Hospital

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-16
Primary Completion
2019-07-24
Completion
2019-07-24

Countries

  • United Arab Emirates

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03082976 on ClinicalTrials.gov